Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Biological Psychiatry|January 28, 2003
Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trialJonathan R T Davidson, Richard H Weisler, Marian I Butterfield, et al.International Clinical Psychopharmacology|December 17, 2004
Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorderJonathan R T Davidson, Victoria M Payne, Kathryn M Connor, et al.Neurology|August 10, 2014
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine preventionTony W Ho, Kathryn M Connor, Ying Zhang, et al.The International Journal of Neuropsychopharmacology|March 17, 2016
A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary InsomniaKathryn M Connor, Erin Mahoney, Saheeda Jackson, et al.The American Journal of Psychiatry|January 29, 2005
Neuroactive steroids and suicidality in posttraumatic stress disorderMarian I Butterfield, Karen M Stechuchak, Kathryn M Connor, et al.Headache|November 13, 2010
Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trialKathryn M Connor, Sheena K Aurora, Tom Loeys, et al.Journal of Traumatic Stress|November 1, 2006
Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorderBarbara O Rothbaum, Shawn P Cahill, Edna B Foa, et al.The International Journal of Neuropsychopharmacology|June 6, 2017
Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive DisorderKathryn M Connor, Paulette Ceesay, Jill Hutzelmann, et al.Psychopharmacology|February 5, 2008
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findingsNaomi M Simon, Kathryn M Connor, Richard T LeBeau, et al.Headache|May 28, 2009
Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment responseRoger K Cady, Vincent T Martin, Gilles Géraud, et al.Pageof 6